Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12033-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12033-1-AP, RRID:AB_2203934
- Product name
- TM7SF2 antibody
- Antibody type
- Polyclonal
- Description
- TM7SF2 antibody (Cat. #12033-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Dingxin recipe Ⅲ ameliorates atherosclerosis through stard4-mediated regulation of hepatic lipid metabolism.
METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression.
Tylophora yunnanensis extract inhibits cholesterol biosynthesis to suppress triple negative breast cancer.
TM7SF2 as a Potential Biomarker in Colorectal Cancer: Implications for Metastasis.
Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis.
Gu Y, Jin Y, Zhao H, Tang J, Li Z, Cheng S, Zhang Y, He P, Han Z, He J, Zhou F, Liu X, Jia Y
Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 Apr;153:157924
Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 Apr;153:157924
METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression.
Li J, Luo Q, Lu M, Lu C, Xu C, Ding J, Zhan T, Zhu J, Qian M, Lin S, Chang L, Li J, Wang K
International journal of biological sciences 2025;21(11):4782-4797
International journal of biological sciences 2025;21(11):4782-4797
Tylophora yunnanensis extract inhibits cholesterol biosynthesis to suppress triple negative breast cancer.
Feng ZH, Li WY, Li QZ, Zhao FB, Zhang HJ, Zhang L, Zhang H
Journal of ethnopharmacology 2025 May 28;348:119877
Journal of ethnopharmacology 2025 May 28;348:119877
TM7SF2 as a Potential Biomarker in Colorectal Cancer: Implications for Metastasis.
Hong I, Kim S, Lee M, Han S, Kim HC, Chu CW, Kim SG, Kim MK, Kim CJ, Kang DH, Ahn TS, Baek MJ, Hussain M, Kwon HY, Jeong D
Current oncology (Toronto, Ont.) 2025 Feb 17;32(2)
Current oncology (Toronto, Ont.) 2025 Feb 17;32(2)
Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis.
Lewinska M, Juvan P, Perse M, Jeruc J, Kos S, Lorbek G, Urlep Z, Keber R, Horvat S, Rozman D
PloS one 2014;9(11):e112787
PloS one 2014;9(11):e112787
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human lung tissue were subjected to SDS PAGE followed by western blot with 12033-1-AP(TM7SF2 antibody) at dilution of 1:400
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TM7SF2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TM7SF2. This antibody recognizes human,mouse,rat antigen. The TM7SF2 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
